Circulating IGF-2 fell during metformin treatment, but the change did not reach statistical significance ( P = 0.07).
← all excerpts
Insulin-like growth factor role in determining the anti-cancer effect of metformin: RCT in prostate cancer patients.
1
0.0700
0.0700